Formerly doing business as Protein Advances Inc, - renamed in 2014 - PAI Life Sciences is a biotechnology company working in the space of in silico and expert-systems assisted discovery. With a focus on antigens for diagnostics and vaccines, proncipals of the firm are developing novel protein biotherapeutics and have a pipeline of products ranging from infectious disease vaccines and adjuvants to small molecule therapeutics. PAI personnel have developed software platforms and analysis tools that allow for semiautonomous target identification, in silico genomic reduction and sequence analysis/presentation. In collaboration with the Infectious Disease Research Institute, the company is developing diagnostics for clinical and field testing. The company also performs contract programming and identification of bioinformatic solutions.
